A Phase 2 proof-of-concept trial of SB414 as a topical treatment in patients with mild-to-moderate psoriasis

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 13 Jun 2017

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

05 Jun 2017 According to a Novan Inc media release, the company anticipates to initiate this study in the third quarter of 2017.
12 May 2017 According to a Novan Inc media release, the company plans to submit an Investigational New Drug application to the U.S. Food and Drug Administration later this quarter for the initiation of this study.
20 Mar 2017 According to a Novan Inc media release, company expects to initiate clinical development of SB414 following an IND submission in the second quarter of 2017.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com